Cue Biopharma (CUE) Price Target Increased by 2,900.00% to 122.40
28/4 05:21
The average one-year price target for Cue Biopharma (NasdaqCM:CUE) has been revised to $122.40 / share. This is an increase of 2,900.00% from the prior estimate of $4.08 dated April 12, 2026. The price target is an average of many targets provided by analysts....